Friday thoughts IMU, page-167

"Sounds like you have a beef with RAC."

I think a lot of biotech investors have problems with RAC.

Maybe it's because it's so ramped up over there, that almost every poster believes it is super safe and going to be worth a fortune.

But you mention "... it was shown to be safe and with little to no side effects", yet in the last trial they had 27 Serious Grade 3 or 4 side effects in just 10 subjects (or maybe even just 9, as one person died (not Race's drug's fault)).

That's a lot of serious side effects (like sepsis). So far imu's drugs haven't recorded one.

And the director is constantly ramping it up, but making it sound like he is doing a favour to the "unknowledgeable" biotech investors out there.

I saw one of his posts which had a throwaway line like "there is barely a day that goes by when I don't find another use for Bisantrene". What's he doing with it? Cleaning his teeth with it or using it to clean behind the U bend?

It's also tauted as a "forgotten" drug. But big pharmas don't just forget about a good asset. I assume they chose not to develop it further.

There is some interesting new pre-clinical data, which Race are persuing.

Maybe Race's drug is the bees knees, but I (like many serious biotech investors) are just not so impressed by how their drug is constantly promoted.

All imho, cheers